Form 4: Arteris Director Executes Planned Stock Sale

Arteris, Inc. Director Antonio J. Viana transferred shares to a family trust and sold 20,839 shares via a 10b5-1 trading plan.

Summary

• Director Antonio J. Viana transferred 20,839 shares of Arteris, Inc. common stock to the Viana Family Trust.
• Following the transfer, the director sold 20,839 shares held by the trust in three separate tranches.
• The sales were executed on June 4, 2026, pursuant to a Rule 10b5-1 trading plan adopted on June 10, 2025.
• The weighted average sale prices for the tranches were $35.4661, $36.5082, and $37.089 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions were executed under a pre-planned 10b5-1 arrangement, which is a standard and transparent method for insider liquidity.

Positives

• The transactions were conducted under a pre-established 10b5-1 trading plan, indicating the sales were scheduled in advance rather than based on non-public information.

Negatives

• The director reduced his total beneficial ownership in the company through these sales.

Risks

• Insider selling can sometimes be perceived negatively by the market as a signal of management's view on current valuation.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider selling via 10b5-1 plans is a standard corporate governance practice and generally does not reflect a change in the company's fundamental outlook or strategic direction.

Comparison to Industry Standards

• The use of 10b5-1 plans is the industry standard for corporate insiders to divest shares while maintaining compliance with SEC regulations.

Related Party Transactions

• Transfer of 20,839 shares from Antonio J. Viana to the Viana Family Trust, for which the reporting person serves as trustee.

Stakeholder Impact

• Minimal impact expected as the sales were pre-planned and represent a small portion of total outstanding shares.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Arteris, AIP, Insider Trading, Form 4, 10b5-1, Director Sale